Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
30 Apr 24
8-K
Labcorp Announces 2024 First Quarter Results
25 Apr 24
8-K
Labcorp Declares Quarterly Dividend
11 Apr 24
ARS
2023 FY
Annual report to shareholders
4 Apr 24
DEFA14A
Additional proxy soliciting materials
4 Apr 24
DEF 14A
Definitive proxy
4 Apr 24
8-K
Regulation FD Disclosure
27 Mar 24
10-K
2023 FY
Annual report
26 Feb 24
8-K
Labcorp Announces 2023 Fourth Quarter and Full Year Results
15 Feb 24
8-K
Regulation FD Disclosure
16 Jan 24
8-K
Labcorp Declares Quarterly Dividend
12 Jan 24
8-K
Labcorp to Speak at the 42ND Annual J.P. Morgan Healthcare Conference
2 Jan 24
10-Q
2023 Q3
Quarterly report
30 Oct 23
8-K
Labcorp Announces 2023 Third Quarter Results
26 Oct 23
8-K
Labcorp Declares Quarterly Dividend
12 Oct 23
8-K
Regulation FD Disclosure
29 Sep 23
8-K
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
14 Sep 23
8-K
Departure of Directors or Certain Officers
11 Sep 23
8-K
Regulation FD Disclosure
9 Aug 23
10-Q
2023 Q1
Quarterly report
4 Aug 23
8-K
Regulation FD Disclosure
31 Jul 23
8-K
Labcorp Announces 2023 Second Quarter Results
27 Jul 23
8-K
Labcorp Declares Quarterly Dividend
13 Jul 23
8-K/A
Financial Statements and Exhibits
7 Jul 23
8-K
Labcorp Completes Spin-off of Fortrea
3 Jul 23
8-K
Regulation FD Disclosure
29 Jun 23
8-K
Labcorp Announces Additional Information in Connection with its Spin-off of Fortrea
12 Jun 23
8-K
Labcorp Announces Information in Connection with its Spin-off of Fortrea
9 Jun 23
8-K
Labcorp Announces Launch of Fortrea’s Notes Offering in Connection With Anticipated Spinoff
8 Jun 23
8-K
Labcorp Appoints Dr. Paul Rothman to Board of Directors
7 Jun 23
SD
Conflict minerals disclosure
31 May 23
8-K
Submission of Matters to a Vote of Security Holders
15 May 23
8-K/A
Departure of Directors or Certain Officers
5 May 23
8-K/A
Departure of Directors or Certain Officers
5 May 23
8-K
Departure of Directors or Certain Officers
4 May 23
8-K
Departure of Directors or Certain Officers
4 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Labcorp to Webcast Its Annual Meeting of Shareholders
4 May 23
DEFA14A
Additional proxy soliciting materials
2 May 23
8-K
Labcorp Announces 2023 First Quarter Results
25 Apr 23
Latest ownership filings
144
Notice of proposed sale of securities
30 Apr 24
4
GLENN A EISENBERG
17 Apr 24
4
Mark S Schroeder
3 Apr 24
4
Amy B. Summy
3 Apr 24
4
Megan D. Bailey
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
der Vaart Sandra D van
29 Mar 24
4
Brian J Caveney
29 Mar 24
4
Mark S Schroeder
29 Mar 24
4
Adam H Schechter
29 Mar 24
4
Jonathan P. DiVincenzo
29 Mar 24
4
Peter J Wilkinson
29 Mar 24
4
Amy B. Summy
29 Mar 24
4
GLENN A EISENBERG
29 Mar 24
4
LANCE BERBERIAN
29 Mar 24
144
Notice of proposed sale of securities
28 Mar 24
4
Mark S Schroeder
11 Mar 24
4
Amy B. Summy
11 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
4
GLENN A EISENBERG
22 Feb 24
4
Jonathan P. DiVincenzo
22 Feb 24
144
Notice of proposed sale of securities
21 Feb 24
144
Notice of proposed sale of securities
21 Feb 24
4
der Vaart Sandra D van
15 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Adam H Schechter
13 Feb 24
4
GLENN A EISENBERG
13 Feb 24
4
Jonathan P. DiVincenzo
13 Feb 24
4
Brian J Caveney
13 Feb 24
4
LANCE BERBERIAN
13 Feb 24
4
Mark S Schroeder
13 Feb 24
4
Amy B. Summy
13 Feb 24
4
der Vaart Sandra D van
13 Feb 24
4
Peter J Wilkinson
13 Feb 24
144
Notice of proposed sale of securities
13 Feb 24
4
der Vaart Sandra D van
9 Feb 24
4
Adam H Schechter
8 Feb 24
4
GLENN A EISENBERG
8 Feb 24